AAD 2026Abstract 76863
Efficacy of Oral DFD-29, a Low-Dose Minocycline Formulation, by Baseline Rosacea Severity in Two Phase 3 Trials
Sidgiddi S, Gold LS, Gallo R, Dhawan S, Bayar S, Sidgiddi S
AAD Annual Meeting 2026Denver, 27–31 Mar 2026 · published in JAAD 6 Jul 2026
Topics: Rosacea
Abstract
The abstract’s text is on the JAAD website.
DOI 10.1016/j.jaad.2026.04.783 · Not in PubMed: details from Crossref